GRAIL, Inc. (Nasdaq: GRAL), a healthcare company focused on early cancer detection, has announced the issuance of equity awards to 38 newly hired non-executive employees. These awards, in the form of restricted stock units (RSUs) totaling 77,350 shares of GRAIL's common stock, serve as inducements for their acceptance of employment. The awards were granted under GRAIL's Inducement Equity Incentive Plan in alignment with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over approximately four years, with 25% vesting on May 31, 2026, and subsequent vesting on each anniversary of this date, contingent on continued employment with the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.